Literature DB >> 4035725

Abnormal stem cells in autoimmune-prone mice are responsible for premature thymic involution.

T Nakamura, S Ikehara, R A Good, S Inoe, K Sekita, F Furukawa, H Tanaka, M M Oo, Y Hamashima.   

Abstract

Autoimmune-prone mice show premature thymic involution, including morphological and functional abnormalities. To determine why the thymic abnormalities develop in autoimmune-prone mice, transplantation of the thymus and/or bone marrow was performed. When thymuses of newborn MRL/1 (H-2k) mice were grafted into C3H/HeN nu/nu(H-2k) mice, the engrafted thymuses did not show the abnormalities which characterize the thymus in the autoimmune-prone MRL/1 mice. By contrast, when thymuses of newborn C3H/HeN or MRL/n mice were grafted into MRL/1 mice, the engrafted thymuses developed after an interval of 3 months the same morphological abnormalities as were seen in MRL/1 mice. Thus, we can conclude that premature involution of the thymus in autoimmune-prone mice may not be a genetically determined abnormality intrinsic to the thymus, but rather an abnormality secondary to other events occurring in these mice. When bone marrow of young C3H/HeN nu/nu mice was transplanted into irradiated (850 rad) MRL/1 mice, neither thymic abnormalities nor autoimmune diseases developed. Therefore, it seem likely that abnormal stem cells in autoimmune-prone mice induce thymic abnormalities, and these, in turn, are associated with the development of autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4035725

Source DB:  PubMed          Journal:  Thymus        ISSN: 0165-6090


  8 in total

1.  Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells.

Authors:  S Ikehara; M Kawamura; F Takao; M Inaba; R Yasumizu; S Than; H Hisha; K Sugiura; Y Koide; T O Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Prevention of development of autoimmune disease in BXSB mice by mixed bone marrow transplantation.

Authors:  B Y Wang; N S El-Badri; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

3.  Transplantation of wheat germ agglutinin-positive hematopoietic cells to prevent or induce systemic autoimmune disease.

Authors:  E E Sardiña; K Sugiura; S Ikehara; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

4.  Effective treatment of autoimmune disease and progressive renal disease by mixed bone-marrow transplantation that establishes a stable mixed chimerism in BXSB recipient mice.

Authors:  B Wang; Y Yamamoto; N S El-Badri; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

5.  Thymus reticulum of autoimmune mice. 3. Ultrastructural study of NOD (non-obese diabetic) mouse thymus.

Authors:  B Nabarra; I Andrianarison
Journal:  Int J Exp Pathol       Date:  1991-06       Impact factor: 1.925

6.  Abnormal surface markers expression on bone marrow CD34+ cells and correlation with disease activity in patients with systemic lupus erythematosus.

Authors:  Ling-Yun Sun; Kang-Xin Zhou; Xue-Bing Feng; Hua-Yong Zhang; Xue-Qin Ding; Ou Jin; Li-Wei Lu; Chak-Sing Lau; Ya-Yi Hou; Le-Ming Fan
Journal:  Clin Rheumatol       Date:  2007-04-20       Impact factor: 2.980

7.  Attenuation of lpr-graft-versus-host disease (GVHD) in MRL/lpr spleen cell-injected SCID mice by in vivo treatment with anti-V beta 8.1,2 monoclonal antibody.

Authors:  N Hosaka; N Nagata; S Miyashima; S Ikehara
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

8.  Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation.

Authors:  S Ikehara; R Yasumizu; M Inaba; S Izui; K Hayakawa; K Sekita; J Toki; K Sugiura; H Iwai; T Nakamura
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.